Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a ...
The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...
Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).
Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...
To calculate adjusted net income (loss), adjusted net income (loss) attributable to Boston Scientific common stockholders ... deferred tax expenses (benefits) and certain discrete tax items.
Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy. Now, it has resumed its work to see whether its Farapulse platform can ...
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: ...